Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methotrexate in dermatology.

Carolyn A Bangert1, Melissa I Costner

  • 1Department of Dermatology, University of Texas Medical School at Houston, Houston, Texas 77030, USA. Carolyn.Bangert@utsouthwestern.edu

Dermatologic Therapy
|November 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diffuse Large B-Cell Lymphoma at the Site of a Herpes Zoster Scar.

World journal of oncology·2017
Same author

A rare case of cutaneous acanthamoebiasis in a renal transplant patient.

Dermatology online journal·2017
Same author

Nodular Scleroderma Revisited: Systemic Sclerosis Presenting as Annular Keloidal Sclerotic Plaques.

The Journal of clinical and aesthetic dermatology·2016
Same author

JAAD grand rounds quiz. A 40-year-old man with hyperkeratotic palms and soles. Papillone-Lefèvre syndrome.

Journal of the American Academy of Dermatology·2012
Same author

Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.

The Journal of investigative dermatology·2012
Same author

Angioedema-type swelling and herpes simplex virus reactivation following hyaluronic acid injection for lip augmentation.

Journal of the American Academy of Dermatology·2011
Same journal

Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.

Dermatologic therapy·2024
Same journal

Correction to "Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis".

Dermatologic therapy·2022
Same journal

A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib.

Dermatologic therapy·2022
Same journal

A case report of vitiligo following toripalimab therapy for a patient with metastatic melanoma.

Dermatologic therapy·2022
Same journal

High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts.

Dermatologic therapy·2022
Same journal

Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.

Dermatologic therapy·2022
See all related articles

Methotrexate, a folic acid analog, is a long-standing treatment for inflammatory skin diseases. New research explores its anti-inflammatory effects and genetic factors to optimize therapy and predict side effects.

Area of Science:

  • Dermatology
  • Pharmacology
  • Immunology

Background:

  • Methotrexate is a folic acid analog with over 40 years of use in dermatology for cutaneous diseases.
  • It possesses antiproliferative and anti-inflammatory properties, the latter linked to adenosine pathways.

Purpose of the Study:

  • To review methotrexate's pharmacokinetics, administration, dosing, side effects, and interactions.
  • To provide practical guidelines for methotrexate therapy initiation and adjustment.
  • To summarize emerging research on its mechanism of action and future therapeutic potential.

Main Methods:

  • Literature review of existing studies on methotrexate.
  • Analysis of pharmacokinetic and pharmacodynamic data.
  • Synthesis of current research on mechanisms and genetic variations.

Related Experiment Videos

Main Results:

  • Established efficacy and safety profile of methotrexate in various dermatological conditions.
  • Identified anti-inflammatory mechanisms beyond antiproliferation, involving adenosine.
  • Highlighted the role of genetic variations in predicting treatment response and adverse events.

Conclusions:

  • Methotrexate remains a cornerstone therapy for numerous skin diseases.
  • Understanding its adenosine-related anti-inflammatory effects and genetic factors can personalize treatment.
  • Further research promises optimized methotrexate therapy and improved patient outcomes.